Report Detail
Global (United States, European Union and China) Breast Cancer Predictive Genetic Testing Market Research Report 2019-2025
- RnM3486798 |
- 04 June, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
In 2019, the market size of Breast Cancer Predictive Genetic Testing is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Breast Cancer Predictive Genetic Testing.
This report studies the global market size of Breast Cancer Predictive Genetic Testing, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Breast Cancer Predictive Genetic Testing sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Roche
Thermo Fisher Scientific
PerkinElmer
Quest Diagnostics
Myriad Genetics
Iverson Genetics
Cancer Genetics
OncoCyte Corporation
NeoGenomics
Invitae
Market Segment by Product Type
High Penetrant Genes
Intermediate Penetrant Genes
Low Penetrant Genes
Market Segment by Application
Hospitals
Clinics
Other
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Breast Cancer Predictive Genetic Testing status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Breast Cancer Predictive Genetic Testing manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Breast Cancer Predictive Genetic Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Type (2019-2025)
- 1.3.2 High Penetrant Genes
- 1.3.3 Intermediate Penetrant Genes
- 1.3.4 Low Penetrant Genes
- 1.4 Market Segment by Application
- 1.4.1 Global Breast Cancer Predictive Genetic Testing Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Clinics
- 1.4.4 Other
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Breast Cancer Predictive Genetic Testing Market Size
- 2.1.1 Global Breast Cancer Predictive Genetic Testing Revenue 2014-2025
- 2.1.2 Global Breast Cancer Predictive Genetic Testing Sales 2014-2025
- 2.2 Breast Cancer Predictive Genetic Testing Growth Rate by Regions
- 2.2.1 Global Breast Cancer Predictive Genetic Testing Sales by Regions 2014-2019
- 2.2.2 Global Breast Cancer Predictive Genetic Testing Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Breast Cancer Predictive Genetic Testing Sales by Manufacturers
- 3.1.1 Breast Cancer Predictive Genetic Testing Sales by Manufacturers 2014-2019
- 3.1.2 Breast Cancer Predictive Genetic Testing Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Breast Cancer Predictive Genetic Testing Revenue by Manufacturers (2014-2019)
- 3.2.2 Breast Cancer Predictive Genetic Testing Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Breast Cancer Predictive Genetic Testing Market Concentration Ratio (CR5 and HHI)
- 3.3 Breast Cancer Predictive Genetic Testing Price by Manufacturers
- 3.4 Key Manufacturers Breast Cancer Predictive Genetic Testing Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Breast Cancer Predictive Genetic Testing Market
- 3.6 Key Manufacturers Breast Cancer Predictive Genetic Testing Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 High Penetrant Genes Sales and Revenue (2014-2019)
- 4.1.2 Intermediate Penetrant Genes Sales and Revenue (2014-2019)
- 4.1.3 Low Penetrant Genes Sales and Revenue (2014-2019)
- 4.2 Global Breast Cancer Predictive Genetic Testing Sales Market Share by Type
- 4.3 Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Type
- 4.4 Breast Cancer Predictive Genetic Testing Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Breast Cancer Predictive Genetic Testing Sales by Application
6 United States
- 6.1 United States Breast Cancer Predictive Genetic Testing Breakdown Data by Company
- 6.2 United States Breast Cancer Predictive Genetic Testing Breakdown Data by Type
- 6.3 United States Breast Cancer Predictive Genetic Testing Breakdown Data by Application
7 European Union
- 7.1 European Union Breast Cancer Predictive Genetic Testing Breakdown Data by Company
- 7.2 European Union Breast Cancer Predictive Genetic Testing Breakdown Data by Type
- 7.3 European Union Breast Cancer Predictive Genetic Testing Breakdown Data by Application
8 China
- 8.1 China Breast Cancer Predictive Genetic Testing Breakdown Data by Company
- 8.2 China Breast Cancer Predictive Genetic Testing Breakdown Data by Type
- 8.3 China Breast Cancer Predictive Genetic Testing Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Breast Cancer Predictive Genetic Testing Breakdown Data by Company
- 9.2 Rest of World Breast Cancer Predictive Genetic Testing Breakdown Data by Type
- 9.3 Rest of World Breast Cancer Predictive Genetic Testing Breakdown Data by Application
- 9.4 Rest of World Breast Cancer Predictive Genetic Testing Breakdown Data by Countries
- 9.4.1 Rest of World Breast Cancer Predictive Genetic Testing Sales by Countries
- 9.4.2 Rest of World Breast Cancer Predictive Genetic Testing Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Roche
- 10.1.1 Roche Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Breast Cancer Predictive Genetic Testing
- 10.1.4 Breast Cancer Predictive Genetic Testing Product Introduction
- 10.1.5 Roche Recent Development
- 10.2 Thermo Fisher Scientific
- 10.2.1 Thermo Fisher Scientific Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Breast Cancer Predictive Genetic Testing
- 10.2.4 Breast Cancer Predictive Genetic Testing Product Introduction
- 10.2.5 Thermo Fisher Scientific Recent Development
- 10.3 PerkinElmer
- 10.3.1 PerkinElmer Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Breast Cancer Predictive Genetic Testing
- 10.3.4 Breast Cancer Predictive Genetic Testing Product Introduction
- 10.3.5 PerkinElmer Recent Development
- 10.4 Quest Diagnostics
- 10.4.1 Quest Diagnostics Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Breast Cancer Predictive Genetic Testing
- 10.4.4 Breast Cancer Predictive Genetic Testing Product Introduction
- 10.4.5 Quest Diagnostics Recent Development
- 10.5 Myriad Genetics
- 10.5.1 Myriad Genetics Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Breast Cancer Predictive Genetic Testing
- 10.5.4 Breast Cancer Predictive Genetic Testing Product Introduction
- 10.5.5 Myriad Genetics Recent Development
- 10.6 Iverson Genetics
- 10.6.1 Iverson Genetics Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Breast Cancer Predictive Genetic Testing
- 10.6.4 Breast Cancer Predictive Genetic Testing Product Introduction
- 10.6.5 Iverson Genetics Recent Development
- 10.7 Cancer Genetics
- 10.7.1 Cancer Genetics Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Breast Cancer Predictive Genetic Testing
- 10.7.4 Breast Cancer Predictive Genetic Testing Product Introduction
- 10.7.5 Cancer Genetics Recent Development
- 10.8 OncoCyte Corporation
- 10.8.1 OncoCyte Corporation Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Breast Cancer Predictive Genetic Testing
- 10.8.4 Breast Cancer Predictive Genetic Testing Product Introduction
- 10.8.5 OncoCyte Corporation Recent Development
- 10.9 NeoGenomics
- 10.9.1 NeoGenomics Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Breast Cancer Predictive Genetic Testing
- 10.9.4 Breast Cancer Predictive Genetic Testing Product Introduction
- 10.9.5 NeoGenomics Recent Development
- 10.10 Invitae
- 10.10.1 Invitae Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Breast Cancer Predictive Genetic Testing
- 10.10.4 Breast Cancer Predictive Genetic Testing Product Introduction
- 10.10.5 Invitae Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Breast Cancer Predictive Genetic Testing Sales Channels
- 11.2.2 Breast Cancer Predictive Genetic Testing Distributors
- 11.3 Breast Cancer Predictive Genetic Testing Customers
12 Market Forecast
- 12.1 Global Breast Cancer Predictive Genetic Testing Sales and Revenue Forecast 2019-2025
- 12.2 Global Breast Cancer Predictive Genetic Testing Sales Forecast by Type
- 12.3 Global Breast Cancer Predictive Genetic Testing Sales Forecast by Application
- 12.4 Breast Cancer Predictive Genetic Testing Forecast by Regions
- 12.4.1 Global Breast Cancer Predictive Genetic Testing Sales Forecast by Regions 2019-2025
- 12.4.2 Global Breast Cancer Predictive Genetic Testing Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Breast Cancer Predictive Genetic Testing . Industry analysis & Market Report on Breast Cancer Predictive Genetic Testing is a syndicated market report, published as Global (United States, European Union and China) Breast Cancer Predictive Genetic Testing Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Breast Cancer Predictive Genetic Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
